DIETARY INTERVENTIONS INFLUENCING NEUROLOGICAL OUTCOMES
Carolina Blagojevic Castro
Dietician/Nutritionist,
PhD Candidate at Murdoch University, Western Australia &
Research Assistant, Alzheimer’s Research Australia
RESEARCHER PROFILE
Filmed in Perth, Western Australia | September 2024
With over a decade of experience as a dietitian and nutritionist, Carolina Blagojevic Castro specialises in providing personalised dietary guidance and customised meal planning tailored to meet each client’s unique health needs. She is known for her engaging and educational presentations on topics related to health and nutrition, sharing practical, evidence-based insights with both community groups and professional audiences.
Currently, she works as a Nutritionist and Research Assistant at Alzheimer’s Research Australia, supporting studies on the links between diet and cognitive health. This role deepens her expertise in neurology-related nutrition, allowing her to explore how dietary interventions may influence neurological outcomes. She is also a PhD candidate at the Centre for Healthy Ageing at Murdoch University in Perth, Australia, where she merges her hands-on experience with academic research, contributing practical insights to the field of nutritional science. Her research focuses on the interplay between diet and aging, bridging real-world applications and theoretical knowledge to advance the understanding of nutrition’s impact on healthy aging.
In addition to her role at Murdoch University, she holds a postgraduate qualification in Neurological Diseases from Philadelphia University/UniFil in Brazil, further enhancing her capacity to address complex dietary needs. Her commitment to professional development ensures that she stays at the forefront of advancements in nutrition, providing care to her clients and contributing meaningfully to her field.
You Might also like
-
In his father’s footsteps as a kidney transplant specialist
Since he was a young child, Dr Collins, has been interested in kidney failure and kidney transplants in particular. His father was also a kidney specialist, and he used to sit by the phone when his father, was on call and ringing people who were being offered a kidney transplant. The joy in their voices through this interaction created a lasting and profound impact on Dr Collins. This carried through his career and today he continues to seek better outcomes for Kidney patients.
-
Systems genetics to determine risk of developing diabetes complications
Dr Mara Zeissig is a recently appointed Lab Head within the Tumour Inflammation and Immunotherapy Program at the South Australian immunoGENomics Cancer Institute (SAiGENCI).
Her research focuses on studying immune evasion mechanisms in lung and pancreatic cancers to identify novel ways to increase response to immunotherapy. Her expertise is in genetically engineered mouse models of lung cancer, CRISPR-Cas9 screening technologies and T cell based immunotherapies (e.g Checkpoint inhibitors). -
Therapies for chronic myeloid leukaemia
Professor Tim Hughes is an international expert in the biology and treatment of leukaemia. He led the establishment of the molecular response criteria that are used world-wide to measure response in chronic myeloid leukaemia (CML) and has led many of the key Global and National trials. His group has successfully developed predictive bioassays and molecular targets that influence the way CML patients are managed world-wide. He has published over 350 papers that have been cited over 65,000 times.